Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by zamani11on Jan 21, 2013 1:29pm

151 Views

Post# 20867426

Who is selling?

If you are correct in your analysis duediligencedon..., then who is selling millions?

Also take a look at Insider trading.. Don't you think if this baby was a good investment, the insiders would take this opportunity and buy cheap shares? After all some of them have options at 50 CENTS.

So Insiders are not buying AT all. In fact the last insider sale was 6 mil at 0.015 cents.

So please stop accusing me of trying to bottom feed. I am just stating the obvious.

Don't think we are smarter them institutional inverstors... They are making cheap shares available

at 0.015 for everyoen to buy and once in a while they buy it themselves to show demand and there it goes again... until they drain it and take as much as they can..before they do 20 to 1 or delist.

Bullboard Posts

2024, a breakthrough year for silver